Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Marrone Bio Innovations (MBII) Stock Price

Media coverage about Marrone Bio Innovations (NASDAQ:MBII) has been trending somewhat positive on Tuesday, Accern Sentiment reports. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Marrone Bio Innovations earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave media stories about the basic materials company an impact score of 44.4891800718433 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Shares of Marrone Bio Innovations (NASDAQ MBII) traded up $0.13 during trading hours on Tuesday, reaching $1.32. The company’s stock had a trading volume of 293,500 shares, compared to its average volume of 155,680. The firm has a market capitalization of $41.28, a price-to-earnings ratio of -1.15 and a beta of 0.31. The company has a debt-to-equity ratio of -1.14, a current ratio of 0.69 and a quick ratio of 0.36. Marrone Bio Innovations has a 12 month low of $0.85 and a 12 month high of $2.45.

Separately, HC Wainwright set a $4.00 target price on Marrone Bio Innovations and gave the stock a “buy” rating in a research report on Thursday, December 21st. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $2.50.

TRADEMARK VIOLATION WARNING: This report was posted by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://transcriptdaily.com/2018/01/09/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-marrone-bio-innovations-mbii-stock-price.html.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

Insider Buying and Selling by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply